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Background
The spectrum of clinical manifestations associated with
mutations of the TREX1 gene (a major human 3’-5’ exo-
nuclease which is an essential negative regulator of
autoimmunity) includes systemic lupus erythematosus,
FCL, AGS and retinal vasculopathy with cerebral
leukodystrophy.
Aim and Methods
To further define the clinical spectrum associated with
TREX1 mutations by reporting a series of cases from a
single family.
Results
The index case was a 10 year old Afro-Caribbean boy who
initially presented with a non-progressive developmental
delay and severe chilblains (the chilblains improved with
methotrexate). He developed transient acute ataxia and
flattened affect, with visual and auditory hallucinations.
Parotid swelling, arthritis and proximal myopathy were
noted, but autoantibodies were negative and complement
studies normal. No viruses were detected in CSF or saliva.
EEG was consistent with encephalopathy. Cerebral MRI
was normal but basal ganglia calcification was seen on CT.
Skin histology was consistent with FCL.
His mother and 2 siblings (3 year old brother and
6 year old sister) also had chilblains (each child had a
different father). No other family member had develop-
mental delay, other evidence of autoimmunity or
inherited metabolic disease. Neither sibling had CT evi-
dence of basal ganglia calcification. All 4 affected family
members had heterozygote mutation of the TREX1 gene
(p.Asp18Asn).
Conclusion
FCL is a genodermatosis characterised by painful bluish-
red skin lesions. AGS is a progressive, chronic encepha-
lopathy associated with basal ganglia calcification. FCL
and AGS are proposed to be different clinical manifesta-
tions associated with a variety of TREX1 mutations. Our
cases demonstrate the variation in clinical phenotype
associated with a single TREX1 mutation, ranging from
typical FCL to acute encephalopathy with features sug-
gestive of AGS, in 4 family members.
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